China NT Pharma Group Company Limited (HKG:1011)

Hong Kong · Delayed Price · Currency is HKD

0.3700

-0.0050 (-1.33%)

Jul 30, 2026, 1:00 PM HKT

HKG:1011 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	24.16	24.16	37.96	7.37	-	226.7
Revenue Growth	29.48%	-36.36%	415.34%	-	-	2.24%
Gross Profit	9.61	9.61	5.26	7.37	-	145.46
Operating Income	-12.36	-12.36	-13.23	-56.21	-26.54	-93.47
Net Income	-26.04	-26.04	-53.36	-143.59	-66.41	-149.54
Earnings Per Share	-0.04	-0.04	-0.20	-0.60	-0.35	-0.79
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Agency Services	9.63	9.63	0.37
Healthcare Related Services	14.53	14.53	37.59
Total	24.16	24.16	37.96

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	7.22	7.22	9.62	1.52	5.93	9.44
Total Debt	316.7	316.7	375.95	344.94	826.45	832.11
Net Cash (Debt)	-309.48	-309.48	-366.33	-343.42	-820.52	-822.67
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.50	-0.50	-1.39	-1.44	-4.32	-4.35

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-5.39	-5.39	-9.07	50.48	36.21	-135.34
Capital Expenditures	-0.16	-0.16	-0.18	-10.73	-4.49	-0.65
Free Cash Flow	-5.55	-5.55	-9.24	39.74	31.72	-135.98
Free Cash Flow Growth	-	-	-	25.31%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	39.78%	39.78%	13.86%	100.00%	-	64.16%
Operating Margin	-51.18%	-51.18%	-34.84%	-763.07%	-	-41.23%
Pretax Margin	-108.68%	-108.68%	-140.89%	-453.01%	-	-65.62%
Profit Margin	-107.80%	-107.80%	-140.56%	-1949.36%	-	-65.96%
FCF Margin	-22.96%	-22.96%	-24.35%	539.55%	-	-59.98%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	13.27	13.27	13.27	13.27	13.27
P/FCF Ratio	-	-	-	3.32	4.78	-
PS Ratio	13.24	20.57	1.77	17.90	-	0.49